Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DNA Defense Daily Cream is a topical skincare product developed to protect skin at the cellular level from ultraviolet (UVA) radiation and environmental stressors. Its key active ingredient is cannabidiol (CBD), delivered via the patented CannaXR nanotechnology system (Z-pod Technology), which enhances skin penetration and provides extended release of actives. The cream is clinically proven to reduce UVA-induced nuclear and mitochondrial DNA damage, thereby lowering risks associated with photoaging and potentially reducing the risk of skin cancer. It works by neutralizing free radicals, supporting mitochondrial energy preservation, defending against oxidative stress, and promoting natural cellular repair mechanisms. The formulation complements sunscreen but focuses on internal cellular protection rather than just surface UV filtering[6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on DNA Defense Daily Cream.